Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Sartorius Stedim Biotech SA

Market Cap 16.1B 18.48B 14.84B 13.96B 26.12B 1,742B 26.3B 177B 68.59B 858B 69.37B 67.88B 2,975B P/E 2026 *
41.7x
P/E 2027 * 32.7x
Enterprise Value 18.11B 20.79B 16.7B 15.7B 29.38B 1,959B 29.59B 199B 77.14B 965B 78.02B 76.35B 3,346B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 5.1x
Free-Float
28.47%
Yield 2026 *
0.52%
Yield 2027 * 0.64%
Manager TitleAgeSince
Chief Executive Officer 50 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact 57 -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-1.38%-33.23%-16.75% 154B
+1.54%-1.23%-7.45%-11.00% 100B
-3.59%+4.05%+61.28%+57.49% 57.66B
-1.90%-3.43%-8.40%+48.53% 53.91B
+1.67%-2.29%-14.60%-44.33% 39.02B
-1.32%-3.20% - - 30.8B
+1.74%-3.69%-10.54%-44.30% 27.49B
+1.35%-0.72%+50.47%-9.42% 22.86B
-2.08%+0.57%-15.51%-5.95% 20.68B
Average -0.30%-1.20%+2.75%-3.22% 56.32B
Weighted average by Cap. -0.22%-0.76%-5.91%-2.19%

Financials

2026 *2027 *
Net sales 3.17B 3.64B 2.92B 2.75B 5.14B 343B 5.18B 34.77B 13.5B 169B 13.66B 13.36B 586B 3.5B 4.02B 3.23B 3.04B 5.68B 379B 5.72B 38.41B 14.92B 187B 15.09B 14.76B 647B
Net income 387M 445M 357M 336M 628M 41.9B 633M 4.25B 1.65B 20.65B 1.67B 1.63B 71.56B 486M 558M 448M 422M 789M 52.62B 795M 5.33B 2.07B 25.93B 2.1B 2.05B 89.87B
Net Debt 2.01B 2.31B 1.85B 1.74B 3.26B 217B 3.28B 22.03B 8.56B 107B 8.65B 8.47B 371B 1.76B 2.02B 1.63B 1.53B 2.86B 191B 2.88B 19.34B 7.51B 94.02B 7.6B 7.44B 326B
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!